title: Prednisolone does not prevent the occurrence of nevirapine-induced rashes.
authors.forename: D
authors.initials: D
authors.lastname: Rey
authors.forename: M
authors.initials: M
authors.lastname: Partisani
authors.forename: V
authors.initials: V
authors.lastname: Krantz
authors.forename: G
authors.initials: G
authors.lastname: Kempf
authors.forename: M
authors.initials: M
authors.lastname: Nicolle
authors.forename: E
authors.initials: E
authors.lastname: de Mautort
authors.forename: M
authors.initials: M
authors.lastname: Priester
authors.forename: C
authors.initials: C
authors.lastname: Bernard-Henry
authors.forename: J M
authors.initials: JM
authors.lastname: Lang
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000188:drug therapy*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D000893:Anti-Inflammatory Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D011239:Prednisolone